CDDEP’s India Office Designated a WHO Collaborating Centre for Antimicrobial Resistance
CDDEP, New Delhi has been designated a World Health Organization Collaborating Center (WHO CC) for Antimicrobial Resistance. It is the first such center in India. In that capacity, CDDEP will provide country and regional-level AMR snapshots and an economic rationale for combating AMR to support WHO Member States in implementing their national action plans.
Under the partnership with WHO, CDDEP will provide WHO country offices with a synthesis of country-specific AMR data and priority actions to combat AMR. Further, CDDEP will work with WHO to assemble a regional AMR snapshot every two years which will directly contribute to the WHO headquarters global progress report on combatting AMR. Finally, CDDEP will help develop the economic rationale for investing in addressing AMR.
Boosting innovation to curb AMR?
AMR Innovation Mission UK 2021
The AMR Innovation Mission UK 2021 aims to add to the global curbing of AMR by boosting joint early & translational research, R&D, clinical development, validation, registration and commercialisation of vaccines, microbial diagnostics and antimicrobial products.